Refine
Year of publication
Document Type
- Article (843)
- Preprint (715)
- Part of Periodical (21)
- Conference Proceeding (9)
- Working Paper (8)
- Review (3)
- Book (1)
- Part of a Book (1)
- Contribution to a Periodical (1)
- Report (1)
Language
- English (1579)
- German (23)
- Multiple languages (1)
Has Fulltext
- yes (1603)
Is part of the Bibliography
- no (1603)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- Jets (5)
- ALICE experiment (4)
- Collective Flow (4)
- Inverse kinematics (4)
- Quark-Gluon Plasma (4)
- Quasi-free scattering (4)
- immunotherapy (4)
- ALICE (3)
- Breast cancer (3)
- COVID-19 (3)
- Elastic scattering (3)
- Heavy Ions (3)
- Heavy Quark Production (3)
- Jets and Jet Substructure (3)
- Nuclear reactions (3)
- Polarization (3)
- Radiotherapy (3)
- Spectroscopic factors (3)
- acute myeloid leukemia (3)
- breast cancer (3)
- cirrhosis (3)
- cytokine-induced killer cells (3)
- global change (3)
- portal hypertension (3)
- pp collisions (3)
- screening (3)
- 140Ce (2)
- AML (2)
- Abdominal aortic aneurysm (2)
- Abdominelles Aortenaneurysma (2)
- Accelerators & Beams (2)
- Acute myeloid leukemia (2)
- Adaptive Erwartung (2)
- Aspergillus (2)
- Atomic, Molecular & Optical (2)
- Atrial fibrillation (2)
- Außenwirtschaftliches Gleichgewicht (2)
- Beauty production (2)
- Bipolar disorder (2)
- CIK cells (2)
- Charm physics (2)
- Cirrhosis (2)
- Clinical Global Impression of Change (2)
- Community ecology (2)
- Diagnostik (2)
- Diffraction (2)
- Dravet syndrome (2)
- Dynamisches Gleichgewicht (2)
- Ecological networks (2)
- Elliptic flow (2)
- Embryos (2)
- Endovascular repair (2)
- Endovaskuläre Behandlung (2)
- Erwartungsbildung (2)
- Ewing sarcoma (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Heavy-ion collisions (2)
- Kalman filter (2)
- Klinische Ergebnisse (2)
- Konjunktur (2)
- Leistungsbilanz (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Liver diseases (2)
- MRI (2)
- Mammakarzinom (2)
- NK cells (2)
- NK-92 (2)
- Nachsorge (2)
- Neutropenia (2)
- News and Business Cycles (2)
- Non-small cell lung cancer (2)
- Offene Versorgung (2)
- Offene Volkswirtschaft (2)
- Open Economy DSGE Models (2)
- Open repair (2)
- Outcome (2)
- PTEN (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Pneumonia (2)
- Predictive markers (2)
- Produktivität (2)
- Psychiatric disorders (2)
- Pulmonary embolism (2)
- QCD (2)
- Quarkonium (2)
- RHIC (2)
- Radiative capture (2)
- Real-time Data (2)
- Register (2)
- Registry (2)
- Relativistic heavy-ion collisions (2)
- Richtlinie (2)
- Shell model (2)
- Single electrons (2)
- Single-particle states (2)
- Suicide (2)
- Surgery (2)
- Surgical oncology (2)
- Treatment outcome (2)
- Trend Growth (2)
- USA (2)
- Umfrage (2)
- Wirtschaftswachstum (2)
- X-ray crystallography (2)
- Zahlungsbilanzausgleich (2)
- Zahlungsbilanzungleichgewicht (2)
- allogeneic stem cell transplantation (2)
- biodiversity protection (2)
- boryl anions (2)
- childhood acute myeloid leukemia (2)
- chimeric antigen receptor (2)
- conservation funding (2)
- conservation planning (2)
- convulsive seizures (2)
- decision making (2)
- dentate gyrus (2)
- diagnosis (2)
- elderly (2)
- fenfluramine (2)
- follow‑up (2)
- guideline (2)
- homeostatic plasticity (2)
- household finance (2)
- liver transplantation (2)
- lung cancer (2)
- meningioma (2)
- post-2020 biodiversity targets (2)
- real-world (2)
- refugees (2)
- relapse (2)
- salvage therapy (2)
- soft tissue sarcoma (2)
- spine head (2)
- stability (2)
- status epilepticus (2)
- storage rings (2)
- strategic site selection (2)
- synaptic plasticity (2)
- synaptopodin (2)
- tumor necrosis factor (2)
- 2-aminobenzimidazole (1)
- 3D tissue models (1)
- 5 lipoxygenase (1)
- 9-borafluorene (1)
- 900 GeV (1)
- AB-serum (1)
- ABC transporters (1)
- ABCB1 (1)
- ABCC1 (1)
- ABCG2 (1)
- ACLF (1)
- ACURATE neo (1)
- ADGRE1 (1)
- ADHD (1)
- AGN host galaxies (1)
- AIS (1)
- ALICE detector (1)
- ALL (1)
- APRI (1)
- ARDS (1)
- ATM (1)
- ATPases (1)
- Abdominal infections (1)
- Accelerators & storage rings (1)
- Acquired drug resistance (1)
- Active middle ear implants (1)
- Acute calcolous cholecystitis (1)
- Acute coronary syndrome (1)
- Acute-on-chronic subdural hematoma (1)
- Advanced biliary tract cancer (1)
- Afrotheria (1)
- Allogeneic hematopoietic stem (1)
- Amino acid analysis (1)
- Angiogenesis (1)
- Animal flight (1)
- Animal phylogenetics (1)
- Anti-nuclei (1)
- Antibiotic (1)
- Antibiotic steward-ship (1)
- Antibiotics (1)
- Antiretroviral therapy (1)
- Aortic valve replacement (1)
- Arteria ophthalmica (1)
- Artesunate (1)
- Artificial Intelligence (1)
- Aspergillus fumigatus (1)
- Aspergillus species (1)
- Atomic & molecular beams (1)
- Atomic and Molecular Physics (1)
- Atoms (1)
- Auditory system (1)
- Autorschaft (1)
- B-slope (1)
- BI1361849 (1)
- BRAF (1)
- BRAF mutation (1)
- BRCA1 (1)
- BRCA2 (1)
- BTC (1)
- Beam loss (1)
- Bevacizumab (1)
- Big Data (1)
- Biliary tree stones (1)
- Biodiversity Data (1)
- Bioinformatics (1)
- Biological (1)
- Biological heart valves (1)
- Biomarker (1)
- Biomarkers (1)
- Biomonitoring (1)
- Bioprosthesis (1)
- Bird flight (1)
- Blindness (1)
- Blood plasma (1)
- Bloodstream infections (1)
- Bone conduction devices (1)
- Bone metastases (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Business strategy in drug development (1)
- C3M (1)
- C4M (1)
- CAKUT (1)
- CAR (1)
- CBA (1)
- CD3/CD19 depletion (1)
- CD36 (1)
- CDI (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- CQL (1)
- CRVO (1)
- CTLA-4 (1)
- CV9202 (1)
- CVID (1)
- Caccoleptus (Bicaccoleptus) kacka, Nearctic region (1)
- Cancer (1)
- Cancer detection (1)
- Cancer treatment (1)
- Candida (1)
- Canopy height model (1)
- Capecitabine (1)
- Cardiac troponin (1)
- Catheter ablation (1)
- Cell membranes (1)
- Cell proliferation (1)
- Cell signalling (1)
- Cell-to-Cell Spread (1)
- Central Europe (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Charge-transfer collisions (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- Chemotherapy (1)
- Cherenkov counter: lead-glass (1)
- Chickens (1)
- Chimerism (1)
- Cholecystectomy (1)
- Circadian (1)
- Circular accelerators (1)
- Cleanliness level (1)
- Climate-change ecology (1)
- Clinical study (1)
- Clinical trial (1)
- Closure (1)
- Coalescence (1)
- Cohort studies (1)
- Coincidence measurement (1)
- Cold nuclear matter effects (1)
- Collective Flow, (1)
- Collectivity (1)
- Colon capsule endoscopy (1)
- Colorectal cancer (1)
- Combined immune checkpoint blockade (1)
- Compact astrophysical objects (1)
- Comparison with QCD (1)
- Complementation rate (1)
- Computer-aided drug design (1)
- Congenital anomalies (1)
- Consensus (1)
- Consensus statement (1)
- Conservation (1)
- Coronary heart disease (1)
- Correlation (1)
- Couch tracking (1)
- Covid-19 (1)
- Critical care (1)
- Critical point (1)
- Cross sections (1)
- Cryoballoon (1)
- Cryoelectron microscopy (1)
- Cryoelectron tomography (1)
- Cultural Influences on Economic Behavior (1)
- Culture positive (1)
- Current Account (1)
- DNA sequence analysis (1)
- DNA-PK (1)
- DNA/LNA mixmers (1)
- DST (1)
- Data sharing (1)
- De-isolation (1)
- Death rates (1)
- Dermis (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- Diagnosis (1)
- Diagnostic differentiation (1)
- Diagnostic markers (1)
- Digestive system procedures (1)
- Digital (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital mammography (1)
- Digitization (1)
- Direct nuclear reactions (1)
- Direct oral anticoagulation (1)
- Direct reactions (1)
- Drug susceptibility testing (1)
- Drug therapy (1)
- EGFR (1)
- EGFR inhibitor (1)
- EMR1 (1)
- EPR (1)
- ERBB2 (1)
- ERBB2 (HER2/neu) (1)
- ESBL (1)
- Earth sciences (1)
- Ecological modelling (1)
- Ecology (1)
- Economics (1)
- Ecosystem ecology (1)
- Eicosanoids (1)
- Electromagnetic transitions (1)
- Electron-pion identification (1)
- Electronic cigarettes (1)
- Electronic transitions (1)
- Electroweak interaction (1)
- Elephants (1)
- Ellenberg indicator values (1)
- Endocrinology (1)
- Endoscopic ultrasound (1)
- Endoscopy (1)
- Enterobacteriaceae (1)
- Epstein-Barr virus (1)
- Equity (1)
- Esophagectomy (1)
- Europe (1)
- European Dry Grassland Group (1)
- European Society for Immunodeficiencies (ESID) (1)
- Eutheria (1)
- Evidence-based guidelines (1)
- Evolutionary biology (1)
- Exosomes (1)
- Extended donor criteria (1)
- F4/80 (1)
- F508del homozygous (1)
- FDG-PET/CT (1)
- FHIR (1)
- FHIR Search (1)
- FIB-4 (1)
- Falciparum (1)
- Fast Healthcare Interoperability Resources (1)
- Fatty acids (1)
- Fatty liver (1)
- Fc receptor (1)
- Feathers (1)
- Femtoscopy (1)
- Festuco-Brometea (1)
- Fevers (1)
- Fibre/foam sandwich radiator (1)
- Fibroblast growth factor (1)
- Fibroblasts (1)
- Filler (1)
- Filovirus cell entry; attachment factors redundancy; SH-SY5Y cell line; host–pathogen interactions (1)
- Fistula (1)
- Flow (1)
- Fmoc solid phase peptide synthesis (1)
- Follow-up (1)
- Fusarium (1)
- GWAS (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Galaxies and clusters (1)
- Galietalia veri (1)
- Gallbladder percutaneous drainage (1)
- Gene expression (1)
- Genetics (1)
- Genetics research (1)
- German PID-NET registry (1)
- Gimbaled tracking (1)
- Glabella (1)
- Glioblastoma (1)
- Glioblastoma survival (1)
- Gouvernementalität (1)
- Gram negative bacteria (1)
- Green fluorescent protein (1)
- Groomed jet radius (1)
- Guadeloupe Archipelago (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- Guidelines (1)
- HADES (1)
- HBT (1)
- HBV (1)
- HER2-positive (1)
- HER2/neu (1)
- HIPPO signalling (1)
- HIV (1)
- HL7 FHIR (1)
- HNSCC (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronization (1)
- Haematopoietic stem cells (1)
- Hand-foot syndrome (1)
- Hard Scattering (1)
- Head and neck cancer (1)
- Head neck cancer (1)
- Health economics (1)
- Health policy (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion collisions (1)
- Heavy ion storage ring (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion (1)
- Hegemonie (1)
- Hematopoietic stem cell transplantation (1)
- Hepatitis c (1)
- Hepatocellular carcinoma (1)
- Herbaria (1)
- Hereditary breast cancer (1)
- Hereditary ovarian cancer (1)
- Hif-1 alpha (1)
- Hif1α (1)
- High-energy astrophysics (1)
- High-energy neutron detection (1)
- Higher moments (1)
- Hospitals (1)
- Household Finance (1)
- Household Portfolios (1)
- Hsp70 (1)
- Human behaviour (1)
- Hypofractionated radiotherapy (1)
- Hyraxes (1)
- ICU (1)
- IHC (1)
- IL-15 (1)
- IL-21 (1)
- IL-6 (1)
- IR (1)
- ISS (1)
- IgG substitution therapy (1)
- Immune response (1)
- Immunity (1)
- Immunogenetics (1)
- Immunology (1)
- Immunology and Microbiology Section (1)
- Immunomonitoring (1)
- Immunotherapy (1)
- In vitro (1)
- Inclusive spectra (1)
- Incomplete colonoscopy (1)
- Induction chemotherapy (1)
- Induction therapy (1)
- Infection (1)
- Inflammation (1)
- Influenza (1)
- Intensity interferometry (1)
- Intensive care units (1)
- Interference fragmentation function (1)
- Interleukin-17A (1)
- Intra-abdominal infection (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Ions (1)
- Ipilimumab (1)
- Isoscalar giant resonances (1)
- J/ψ suppression (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jet substructure (1)
- KLK5 (1)
- KOOS IV (1)
- KPS (1)
- Kidney diseases (1)
- Koelerio-Corynephoretea (1)
- LCH (1)
- Langerhans cell histiocytosis (1)
- Laparostomy (1)
- Library screening (1)
- Lifestyle (1)
- Literarischer Stil (1)
- Literaturwissenschaft (1)
- Liver (1)
- Liver cancer (1)
- Low & intermediate-energy accelerators (1)
- Low volume prep (1)
- Low-molecular-weight heparin (1)
- Luciferase (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- MACS (1)
- MCP-1 (1)
- MGMT (1)
- MLC tracking (1)
- MLL (1)
- MMP9 (1)
- MRP4 (1)
- MYC (1)
- Machine learning (1)
- Macrotomini (1)
- Magnetic resonance (1)
- Malaria (1)
- Mammalian genomics (1)
- Mammals (1)
- Material budget (1)
- Mechanisms of disease (1)
- Medical imaging (1)
- Melanoma (1)
- Menthol (1)
- Mesh (1)
- Metabolism (1)
- Methicillin-resistant Staphylococcus aureus (1)
- MicroRNAs (1)
- Microscopy (1)
- Mid-rapidity (1)
- Minimal residual disease (1)
- Minimum Bias (1)
- Mitoxantrone (1)
- Mixed hearing loss (1)
- Models & methods for nuclear reactions (1)
- Molecular diagnostic testing (1)
- Molecular medicine (1)
- Molecular neuroscience (1)
- Monitoring (1)
- Monte Carlo (1)
- Moviprep (1)
- Multi-Parton Interactions (1)
- Multi-neutron detection (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multidrug-resistant organisms (1)
- Multimodal imaging (1)
- Multiomics (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- Mutation databases (1)
- Mycobacteria (1)
- Mycobacterium avium complex (1)
- Myocardial infarction (1)
- NADPH oxidase (1)
- NAFLD (1)
- NOTCH (1)
- NSCLC (1)
- NTM (1)
- Neoadjuvant therapy (1)
- Neoliberalismus (1)
- Neolithic (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Network analysis (1)
- Neural network (1)
- Neutron physics (1)
- Nicotine (1)
- Nivolumab (1)
- Non-trauma (1)
- Non-tuberculous mycobacteria (1)
- Nonflow (1)
- Noninferiority (1)
- Nontuberculous mycobacteria (1)
- Nox1 (1)
- NoxO1 (1)
- Nuclear astrophysics (1)
- Nuclear modification factor (1)
- Nuclear physics of explosive environments (1)
- Nuclear resonance fluorescence (1)
- Nuclear structure & decays (1)
- Nucleon induced nuclear reactions (1)
- Nutrition (1)
- Obesity (1)
- Occlusion (1)
- Omics (1)
- Oncogenes (1)
- Oncology (1)
- One-nucleon removal (1)
- Open abdomen (1)
- Open pulmonary tuberculosis (1)
- Ophthalmoplegia (1)
- Opportunistic infections (1)
- Orbital electron capture (1)
- Organ allocation (1)
- Organ motion (1)
- Osteoporosis (1)
- Oxaliplatin (1)
- P2X7 receptor (1)
- PD-1 (1)
- PDGFRβ (1)
- PELDOR (1)
- PGE2 (1)
- PI3K (1)
- PID prevalence (1)
- PLX4032 (1)
- PLX4720 (1)
- PYTHIA (1)
- Pancreas transplantation (1)
- Pancreatitis (1)
- Pandemic (1)
- Panel testing (1)
- Parainfluenza (1)
- Particle and Resonance Production (1)
- Pathological complete response (1)
- Pathology (1)
- Patient safety (1)
- Patterns of care (1)
- Pb isotopes (1)
- Pb–Pb (1)
- Peritonitis (1)
- Personalized medicine (1)
- Perturbative methods (1)
- Phospho-soda (1)
- Phosphorylation (1)
- Photon counting (1)
- PillCamColon2 (1)
- Plant sciences (1)
- Plasmodium (1)
- Plastic scintillator array (1)
- Platelets (1)
- Polyps (1)
- Population-based screening (1)
- Portal veins (1)
- Post-Neoliberalismus (1)
- Poverty (1)
- Pre-emptive immunotherapy (1)
- Preoperative radiochemotherapy (1)
- Production Cross Section (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Prostaglandin (1)
- Prostate cancer (1)
- Protease inhibitor therapy (1)
- Proton-proton collisions (1)
- Proton–proton (1)
- Proton–proton collisions (1)
- Pseudo HE-images (1)
- Psoriasis vulgaris (1)
- Psychiatry (1)
- Pygmy Dipole Resonance (1)
- Pyogenic spondylodiscitis (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quasi-particle phonon model (1)
- Quinine (1)
- RMS (1)
- RNA induced silencing complex (1)
- RNA recognition (1)
- RNA, long noncoding (1)
- Radiation detectors (1)
- Radio continuum emission (1)
- Radio jets (1)
- Radiofrequency (1)
- Raman spectroscopy (1)
- Rapidity Range (1)
- Re-exploration (1)
- Reactions with relativistic radioactive beams (1)
- Reactive oxygen species (1)
- Recall rate (1)
- Rectal cancer (1)
- Red blood cell transfusion (1)
- Registries (1)
- Rehabilitation (1)
- Rehospitalization (1)
- Reintervention (1)
- Rejection (1)
- Relativistic heavy ion physics (1)
- Renal lesions (1)
- Research Infrastructure (1)
- Resolution Parameter (1)
- Resonance reactions (1)
- Respiratory infections (1)
- Respiratory syncytial virus (1)
- Retinal diseases (1)
- Rhaphipodini (1)
- Risk factor (1)
- Robotic tracking (1)
- Rome (1)
- SARS-CoV-2 (1)
- SCCHN (1)
- SD-OCT (1)
- SKALE score (1)
- SLC20A1 (1)
- SMAD (1)
- SPSS (1)
- SR-BI (1)
- STAMPE2 (1)
- STAR (1)
- SVR (1)
- Salivary gland carcinoma (1)
- Scattering of atoms, molecules, clusters & ions (1)
- Scattering theory (1)
- Seasonal variation (1)
- Second Punic War (1)
- Seed beetles (1)
- Seizure (1)
- Self-renewal (1)
- Semantics (1)
- Sequence alignment (1)
- Severe malaria (1)
- Shear viscosity (1)
- Single muons (1)
- Single particle decay spectroscopy (1)
- Small molecules (1)
- Social determinants (1)
- SoftDrop (1)
- Solar insolation (1)
- Sorafenib (1)
- Spectroscopic factors & electromagnetic moments (1)
- Spin alignment (1)
- Spine care (1)
- Splitting function (1)
- Sputum smear-negative (1)
- Standardization (1)
- Status epilepticus (1)
- Stenotrophomonas maltophilia (1)
- Stentoplasty (1)
- Storage ring (1)
- Sunlight (1)
- Superinfection (1)
- Supermassive black holes (1)
- Superoxide (1)
- Surgical risk (1)
- Survival (1)
- Survival analysis (1)
- Synthetic (1)
- Systematic Uncertainty (1)
- TAVR (1)
- TB-therapy (1)
- TEMPO (1)
- TGFB-induced factor homeobox 1 (1)
- TGFβ (1)
- TGIF (1)
- TGR(mREN2)27 (1)
- TOR signalling (1)
- TR (1)
- Tailored medicine (1)
- Taxonomy (1)
- Technical data (1)
- Technique (1)
- Temozolomide (1)
- Therapeutic anticoagulation (1)
- Thermal model (1)
- Thoracic trauma (1)
- Thrombosis (1)
- Thromboxane (1)
- Time Projection Chamber (1)
- Timing (1)
- Tracking (1)
- Transcriptome analysis (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Transversity (1)
- Trauma (1)
- Treatment (1)
- Trigger (1)
- Triple negative (1)
- Two body weak decay (1)
- Type 2 diabetes (1)
- UAV (1)
- USP28 (1)
- Upper respiratory tract infection (1)
- Uveal melanoma (1)
- VEGF (1)
- VEGFR (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- VRE (1)
- Vascular emergencies (1)
- Vector Boson Production (1)
- Veins (1)
- Vemurafenib (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Very long baseline interferometry (1)
- Vesicles (1)
- Vincristine (1)
- Vitreous samples (1)
- Wang resin (1)
- Western Mediterranean (1)
- Western blot (1)
- Western diet (1)
- WoMo score (1)
- X-rays (1)
- Xenon-based gas mixture (1)
- acneiform skin toxicity (1)
- acoustic radiation force impulse imaging (1)
- acute decompensation (1)
- acute leukemia (1)
- acute-on-chronic liver failure (1)
- adaptive cardiac remodelling (1)
- adenocarcinoma (1)
- adjuvant chemotherapy (1)
- age (1)
- age-related macular degeneration (1)
- aging (1)
- alleles (1)
- alternative oxidase (1)
- amphiregulin (1)
- anaemia (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- angiogenesis (1)
- angiopoietin-2 (1)
- anterior chamber depth changes (1)
- antibiotic therapy (1)
- anticonvulsants (1)
- antiepileptic drugs (1)
- antifungal activity (1)
- antimicrobial stewardship (1)
- antiviral therapy (1)
- aortic stenosis (1)
- argonaute protein (1)
- artifacts (1)
- ascites (1)
- astrocyte heterogeneity (1)
- atherosclerosis (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- autism spectrum disorder (1)
- autistic disorder (1)
- axions (1)
- beetle species (1)
- biogeographic legaciese (1)
- bioindication (1)
- biological maturation (1)
- bipolar disorder (1)
- bladder cancer (1)
- bladder exstrophy-epispadias complex (1)
- bone marrow metastasis (1)
- bone metastasis (1)
- boron (1)
- bryophyte (1)
- c-kit (1)
- cPLA2 (1)
- calcium-independent phospholipase A2β (1)
- calorimeter: electromagnetic (1)
- cancer (1)
- cancer immunotherapy (1)
- capture (1)
- carbapenem resistance (1)
- cardiac ischaemia‐reperfusion (1)
- cardiac magnetic resonance (1)
- cataract surgery (1)
- cell therapy (1)
- cell transplantation (1)
- cellular therapy (1)
- cerebral sinus and vein thrombosis (CVT) (1)
- cerium (1)
- chemiluminescence (1)
- child (1)
- children and adolescents (1)
- chromosomal translocations (1)
- chronic viral hepatitis (1)
- cleavage of large RNA molecules (1)
- cleavage site selection (1)
- cloacal malformation (1)
- cognitive decline (1)
- collagen degradation marker (1)
- colorectal cancer (1)
- computed tomography (1)
- cone-beam computed tomography (CBCT) (1)
- consensus data set (1)
- conservation (1)
- copy number polymorphism (1)
- coronary disease (1)
- coumarin-4-ylmethyl (1)
- cross-section (1)
- cryo-EM (1)
- cryopreservation (1)
- cyclosporin A (1)
- cystic fibrosis (1)
- cytarabine dose (1)
- cytokine (1)
- cytotoxic T cells (1)
- cytotoxicity (1)
- dE/dx (1)
- dark matter experiments (1)
- data quality (1)
- decompressive craniectomy (1)
- depression (1)
- detector (1)
- dexamethasone (1)
- diabetic macular edema (1)
- disease prevalence (1)
- disease progression (1)
- distributed analysis (1)
- domestication (1)
- drone (1)
- dye labeling (1)
- dysphagia (1)
- early recognition (1)
- ectosomes (1)
- education (1)
- effective lens position (1)
- elderly patients (1)
- electroencephalography (EEG) (1)
- electromagnetic navigation bronchoscopy (EMN, ENB) (1)
- electron transport chain (1)
- electronics: readout (1)
- energy-dispersive x-ray spectroscopy (1)
- epigenomics (1)
- epilepsy (1)
- epiregulin (1)
- eutrophication (1)
- evolution (1)
- ex vivo expansion (1)
- excitation (1)
- exhaustion (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- extraskeletal (1)
- f-MLF (1)
- facial nerve functional outcome (1)
- feasibility study (1)
- federated feasibility queries (1)
- fibre: optical (1)
- fibrotest (1)
- financial literacy (1)
- fine spatial resolution remote sensing (1)
- fluocinolone acetonide (1)
- fluorescence in situ hybridization (FISH) (1)
- flurbiprofen (1)
- forest classification (1)
- forest functional similarity (1)
- formylation (1)
- fresh frozen plasma (1)
- functional genetics (1)
- functional outcome (1)
- fungal sinusitis (1)
- gap junction protein alpha 4-genotype (1)
- gene expression (1)
- gene flow (1)
- genes (1)
- genes for longevity (1)
- genetic generalized epilepsy (1)
- genetic phenotypes (1)
- genetics (1)
- genome (1)
- genotype (1)
- genotype determination (1)
- geriatric medicine (1)
- germ cell tumors (1)
- glioblastoma (1)
- glioblastoma survival (1)
- glioma microenvironment (1)
- growth inhibition (1)
- guanidine analogs (1)
- guidelines (1)
- habitat destruction (1)
- health data (1)
- hearing nerve (1)
- heavy ion experiments (1)
- hepatic encephalopathy (1)
- hepatitis c (1)
- high-dose chemotherapy (1)
- highly-charged ions (1)
- histology (1)
- host plants (1)
- human natural killer cell (1)
- hypertension and anti-hypertensive treatment (1)
- hypertension, pulmonary (1)
- immune checkpoint blockade (1)
- immune infiltration (1)
- immune therapy (1)
- immunity (1)
- immunocytochemistry (1)
- immunohistochemistry (1)
- immunosuppressive agent (1)
- improvement in quality of life (1)
- in silico simulation (1)
- infection control (1)
- inflammasome (1)
- inflammation (1)
- inflammatory markers (1)
- interferon regulatory factor 9 (IRF9) (1)
- interleukin-1β (1)
- interoperability (1)
- intracerebral hemorrhage (ICH) (1)
- invasive fungal infection (1)
- kidney formation (1)
- kidney function (1)
- lamotrigine (1)
- land use (1)
- lapatinib (1)
- levetiracetam (1)
- lichen (1)
- lichen extracts (1)
- liver (1)
- liver cirrhosis (1)
- liver fibrosis (1)
- liver metastasis (1)
- locked nucleic acids (1)
- long-term protection (1)
- long36 term protection (1)
- longitudinal follow-up after epilepsy surgery (1)
- lung disease phenotype (1)
- lung function (1)
- lymphoma (1)
- mRNA (1)
- mRNA active cancer immunotherapy (1)
- macrophage (1)
- magic-angle spinning (1)
- mechanical accuracy (1)
- medical informatics (1)
- membrane proteins (1)
- methylprednisolone (1)
- miRNAs (1)
- microdosing (1)
- microparticles (1)
- microsurgical treatment (1)
- microvesicles (1)
- migration (1)
- minimal clinically important difference (1)
- minimal information requirements (1)
- mixed infection (1)
- molecular machines (1)
- mouse (1)
- mucormycetes (1)
- multicenter study (1)
- multidrug resistance (1)
- multilevel latent polynomial regression analysis (1)
- mycophenolic acid (1)
- myocardial fibrosis (1)
- n_TOF (1)
- natural killer cell (1)
- neoadjuvant therapy (1)
- neovascularization, physiologic (1)
- neuroblastoma (1)
- neutron (1)
- neutrophils (1)
- new species (1)
- nitrogen deposition (1)
- nomenclatural revision (1)
- non-invasive fibrosis assessment (1)
- nucleophilic substitution (1)
- nucleosynthesis (1)
- oligonucleotide (1)
- oligonucleotides (1)
- opportunity (1)
- ovary (1)
- oxLDL (1)
- p+p collisions (1)
- p-hydroxyphenacyl (1)
- p47phox (1)
- pandemic (1)
- patient data (1)
- pediatric (1)
- pediatric cancer (1)
- pediatric patients (1)
- pediatric solid tumors (1)
- perforin (1)
- peritumoral edema (1)
- peritumoral edema zone (1)
- phantom study (1)
- pharmacoresistance (1)
- phenotype (1)
- phenotype/genotype relation (1)
- photoacid generator (1)
- photolabile protection (1)
- photolysis (1)
- phylogenetic community distance (1)
- phylogeny (1)
- plant height (1)
- platelet lysate (1)
- platinum-based chemotherapy (1)
- point shear wave elastography (1)
- polygenic risk score (1)
- portosystemic shunt (1)
- post-transplantation lymphoproliferative disease (1)
- precision medicine (1)
- predictive biomarkers (1)
- predictor (1)
- primary active transporters (1)
- primary immunodeficiency (PID) (1)
- prognosis (1)
- prognostic biomarker (1)
- propagation of inequality (1)
- proteasomal processing escape (1)
- proteasome (1)
- pseudoexfoliative syndrome (1)
- psoriasis (1)
- pull-down (1)
- pulmonary embolism (1)
- quantum electrodynamics test (1)
- quark gluon plasma (1)
- query (1)
- radical reactions (1)
- reactive oxygen species (1)
- recurrence pattern (1)
- redox chemistry (1)
- registry for primary immunodeficiency (1)
- relativistic collisions (1)
- reliable change index (1)
- renin-angiotensin system (1)
- reproducibility (1)
- retrospective trial (1)
- rhabdomyosarcoma (1)
- rigor (1)
- risk assessment (1)
- robot-guided stereotaxy (1)
- rosacea (1)
- s-process (1)
- scar (1)
- schizophrenia (1)
- screening routine (1)
- seizures (1)
- senescence (1)
- sequence alignment (1)
- sex (1)
- signal transduction (1)
- silver coinage (1)
- single nucleotide polymorphism (1)
- single subject classification (1)
- smart home (1)
- smart living (1)
- social identity (1)
- social interactions (1)
- sodium bituminosulfonate (1)
- soil nutrients (1)
- solar physics (1)
- solitary pulmonary nodule (1)
- species richness (1)
- specificity of cleavage (1)
- spectra (1)
- speech and language pathologist (1)
- spontaneous portosystemic shunt (1)
- squamous cell carcinoma (1)
- stage II/III colorectal cancer (1)
- standardization (1)
- standardized regression-based change norms (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- stratification (1)
- stroke (1)
- strong Coulomb field (1)
- structural biology (1)
- structure-from-motion photogrammetry (1)
- subdural hematoma (1)
- subvalent compounds (1)
- surgery (1)
- systematics (1)
- talent development (1)
- talent identification (1)
- targeted therapy (1)
- taxonomy (1)
- telmisartan (1)
- temporal classification (1)
- testis (1)
- therapeutic anticoagulation (1)
- tomography (1)
- trace elements (1)
- trans-Golgi network (1)
- transbronchial biopsy (TBB) (1)
- transcatheter aortic valve replacement (1)
- transfemoral (1)
- transient elastography (1)
- translocation partner genes (1)
- transmission (1)
- trastuzumab (1)
- treatment resistance (1)
- tropical forests (1)
- tumor microenvironment (1)
- tumor microenvironment (TME) (1)
- type I interferons (IFNs) (1)
- umpolung (1)
- urinary tract development (1)
- urothelial carcinoma (1)
- uveal melanoma (1)
- vaccination (1)
- vaccine-induced immune thrombotic thrombocytopenia (VITT) (1)
- valproic acid (1)
- vascular calcification (1)
- vascular dysfunction and inflammation (1)
- vascular endothelial growth factor (1)
- vegetation classification (1)
- vegetation-plot data (1)
- vemurafenib (1)
- versican (VCAN) (1)
- vestibular schwannoma (1)
- viability (1)
- water solubility (1)
- wealth inequality (1)
- web of things (1)
- white and brown dwarfs (1)
- whole-genome sequencing (1)
- women (1)
- x-ray techniques (1)
- youth football (1)
- zebrafish development (1)
- ΔNp63 (1)
- γ-ray spectroscopy (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1209)
- Frankfurt Institute for Advanced Studies (FIAS) (988)
- Informatik (920)
- Medizin (212)
- Geowissenschaften (28)
- ELEMENTS (21)
- Biochemie und Chemie (17)
- Biowissenschaften (14)
- Senckenbergische Naturforschende Gesellschaft (10)
- Institut für Ökologie, Evolution und Diversität (9)
The inclusive J/ψ elliptic (v2) and triangular (v3) flow coefficients measured at forward rapidity (2.5 < y < 4) and the v2 measured at midrapidity (|y| < 0.9) in Pb-Pb collisions at sNN−−−√ = 5.02 TeV using the ALICE detector at the LHC are reported. The entire Pb-Pb data sample collected during Run 2 is employed, amounting to an integrated luminosity of 750 μb−1 at forward rapidity and 93 μb−1 at midrapidity. The results are obtained using the scalar product method and are reported as a function of transverse momentum pT and collision centrality. At midrapidity, the J/ψ v2 is in agreement with the forward rapidity measurement. The centrality averaged results indicate a positive J/ψ v3 with a significance of more than 5σ at forward rapidity in the pT range 2 < pT < 5 GeV/c. The forward rapidity v2, v3, and v3/v2 results at low and intermediate pT (pT ≲ 8 GeV/c) exhibit a mass hierarchy when compared to pions and D mesons, while converging into a species-independent curve at higher pT. At low and intermediate pT, the results could be interpreted in terms of a later thermalization of charm quarks compared to light quarks, while at high pT, path-length dependent effects seem to dominate. The J/ψ v2 measurements are further compared to a microscopic transport model calculation. Using a simplified extension of the quark scaling approach involving both light and charm quark flow components, it is shown that the D-meson vn measurements can be described based on those for charged pions and J/ψ flow.
The invariant differential cross section of inclusive ω(782) meson production at midrapidity (|y|<0.5) in pp collisions at s√=7TeV was measured with the ALICE detector at the LHC over a transverse momentum range of 2<pT<17GeV/c. The ω meson was reconstructed via its ω→π+π−π0 decay channel. The measured ω production cross section is compared to various calculations: PYTHIA 8.2 Monash 2013 describes the data, while PYTHIA 8.2 Tune 4C overestimates the data by about 50%. A recent NLO calculation, which includes a model describing the fragmentation of the whole vector-meson nonet, describes the data within uncertainties below 6GeV/c, while it overestimates the data by up to 50% for higher pT. The ω/π0 ratio is in agreement with previous measurements at lower collision energies and the PYTHIA calculations. In addition, the measurement is compatible with transverse mass scaling within the measured pT range and the ratio is constant with Cω/π0=0.67±0.03~(stat)~±0.04~(sys)~ above a transverse momentum of 2.5GeV/c.
The inclusive J/ψ elliptic (v2) and triangular (v3) flow coefficients measured at forward rapidity (2.5 <y< 4) and the v2 measured at midrapidity (|y|< 0.9) in Pb-Pb collisions at sNN−−−√ = 5.02 TeV using the ALICE detector at the LHC are reported. The entire Pb-Pb data sample collected during Run 2 is employed, amounting to an integrated luminosity of 750 μb−1 at forward rapidity and 93 μb−1 at midrapidity. The results are obtained using the scalar product method and are reported as a function of transverse momentum pT and collision centrality. At midrapidity, the J/ψ v2 is in agreement with the forward rapidity measurement. The centrality averaged results indicate a positive J/ψ v3 with a significance of more than 5σ at forward rapidity in the pT range 2<pT<5 GeV/c. The forward rapidity v2, v3, and v3/v2 results at low and intermediate pT (pT≲8 GeV/c) exhibit a mass hierarchy when compared to pions and D mesons, while converging into a species-independent curve at higher pT. At low and intermediate pT, the results could be interpreted in terms of a later thermalization of charm quarks compared to light quarks, while at high pT, path-length dependent effects seem to dominate. The J/ψ v2 measurements are further compared to a microscopic transport model calculation. Using a simplified extension of the quark scaling approach involving both light and charm quark flow components, it is shown that the D-meson vn measurements can be described based on those for charged pions and J/ψ flow.
The inclusive J/ψ elliptic (v2) and triangular (v3) flow coefficients measured at forward rapidity (2.5 <y< 4) and the v2 measured at midrapidity (|y|< 0.9) in Pb-Pb collisions at sNN−−−√ = 5.02 TeV using the ALICE detector at the LHC are reported. The entire Pb-Pb data sample collected during Run 2 is employed, amounting to an integrated luminosity of 750 μb−1 at forward rapidity and 93 μb−1 at midrapidity. The results are obtained using the scalar product method and are reported as a function of transverse momentum pT and collision centrality. At midrapidity, the J/ψ v2 is in agreement with the forward rapidity measurement. The centrality averaged results indicate a positive J/ψ v3 with a significance of more than 5σ at forward rapidity in the pT range 2<pT<5 GeV/c. The forward rapidity v2, v3, and v3/v2 results at low and intermediate pT (pT≲8 GeV/c) exhibit a mass hierarchy when compared to pions and D mesons, while converging into a species-independent curve at higher pT. At low and intermediate pT, the results could be interpreted in terms of a later thermalization of charm quarks compared to light quarks, while at high pT, path-length dependent effects seem to dominate. The J/ψ v2 measurements are further compared to a microscopic transport model calculation. Using a simplified extension of the quark scaling approach involving both light and charm quark flow components, it is shown that the D-meson vn measurements can be described based on those for charged pions and J/ψ flow.
The measurements of the (anti)deuterons elliptic flow (v2) and the first measurements of triangular flow (v3) in Pb-Pb collisions at a center-of-mass energy per nucleon-nucleon collisions sNN−−−√ = 5.02 TeV are presented. A mass ordering at low transverse momentum (pT) is observed when comparing these measurements with those of other identified hadrons, as expected from relativistic hydrodynamics. The measured (anti)deuterons v2 lies between the predictions from the simple coalescence and blast-wave models, which provide a good description of the data only for more peripheral and for more central collisions, respectively. The mass number scaling, which is violated for v2, is approximately valid for the (anti)deuterons v3. The measured v2 and v3 are also compared with the predictions from a coalescence approach with phase-space distributions of nucleons generated by iEBE-VISHNU with AMPT initial conditions coupled with UrQMD, and from a dynamical model based on relativistic hydrodynamics coupled to the hadronic afterburner SMASH. The model predictions are consistent with the data within the uncertainties in mid-central collisions, while a deviation is observed in central centrality intervals.
The measurements of the (anti)deuterons elliptic flow (v2) and the first measurements of triangular flow (v3) in Pb-Pb collisions at a center-of-mass energy per nucleon-nucleon collisions sNN−−−√ = 5.02 TeV are presented. A mass ordering at low transverse momentum (pT) is observed when comparing these measurements with those of other identified hadrons, as expected from relativistic hydrodynamics. The measured (anti)deuterons v2 lies between the predictions from the simple coalescence and blast-wave models, which provide a good description of the data only for more peripheral and for more central collisions, respectively. The mass number scaling, which is violated for v2, is approximately valid for the (anti)deuterons v3. The measured v2 and v3 are also compared with the predictions from a coalescence approach with phase-space distributions of nucleons generated by iEBE-VISHNU with AMPT initial conditions coupled with UrQMD, and from a dynamical model based on relativistic hydrodynamics coupled to the hadronic afterburner SMASH. The model predictions are consistent with the data within the uncertainties in mid-central collisions, while a deviation is observed in central centrality intervals.
The measurements of the (anti)deuterons elliptic flow (v2) and the first measurements of triangular flow (v3) in Pb-Pb collisions at a center-of-mass energy per nucleon-nucleon collisions sNN−−−√ = 5.02 TeV are presented. A mass ordering at low transverse momentum (pT) is observed when comparing these measurements with those of other identified hadrons, as expected from relativistic hydrodynamics. The measured (anti)deuterons v2 lies between the predictions from the simple coalescence and blast-wave models, which provide a good description of the data only for more peripheral and for more central collisions, respectively. The mass number scaling, which is violated for v2, is approximately valid for the (anti)deuterons v3. The measured v2 and v3 are also compared with the predictions from a coalescence approach with phase-space distributions of nucleons generated by iEBE-VISHNU with AMPT initial conditions coupled with UrQMD, and from a dynamical model based on relativistic hydrodynamics coupled to the hadronic afterburner SMASH. The model predictions are consistent with the data within the uncertainties in mid-central collisions, while a deviation is observed in central centrality intervals.
The invariant differential cross section of inclusive ω(782) meson production at midrapidity (|y|<0.5) in pp collisions at s√ = 7 TeV was measured with the ALICE detector at the LHC over a transverse momentum range of 2 < pT < 17 GeV/c. The ω meson was reconstructed via its ω→π+π−π0 decay channel. The measured ω production cross section is compared to various calculations: PYTHIA 8.2 Monash 2013 describes the data, while PYTHIA 8.2 Tune 4C overestimates the data by about 50%. A recent NLO calculation, which includes a model describing the fragmentation of the whole vector-meson nonet, describes the data within uncertainties below 6 GeV/c, while it overestimates the data by up to 50% for higher pT. The ω/π0 ratio is in agreement with previous measurements at lower collision energies and the PYTHIA calculations. In addition, the measurement is compatible with transverse mass scaling within the measured pT range and the ratio is constant with Cω/π0 = 0.67 ± 0.03 (stat) ± 0.04 (sys) above a transverse momentum of 2.5 GeV/c.
The invariant differential cross section of inclusive ω(782) meson production at midrapidity (|y|<0.5) in pp collisions at s√ = 7 TeV was measured with the ALICE detector at the LHC over a transverse momentum range of 2 < pT < 17 GeV/c. The ω meson was reconstructed via its ω→π+π−π0 decay channel. The measured ω production cross section is compared to various calculations: PYTHIA 8.2 Monash 2013 describes the data, while PYTHIA 8.2 Tune 4C overestimates the data by about 50%. A recent NLO calculation, which includes a model describing the fragmentation of the whole vector-meson nonet, describes the data within uncertainties below 6 GeV/c, while it overestimates the data by up to 50% for higher pT. The ω/π0 ratio is in agreement with previous measurements at lower collision energies and the PYTHIA calculations. In addition, the measurement is compatible with transverse mass scaling within the measured pT range and the ratio is constant with Cω/π0 = 0.67 ± 0.03 (stat) ± 0.04 (sys) above a transverse momentum of 2.5 GeV/c.
Pion–kaon femtoscopy and the lifetime of the hadronic phase in Pb−Pb collisions at √sNN = 2.76 TeV
(2021)
In this paper, the first femtoscopic analysis of pion-kaon correlations at the LHC is reported. The analysis was performed on the Pb-Pb collision data at sNN−−−√ = 2.76 TeV recorded with the ALICE detector. The non-identical particle correlations probe the spatio-temporal separation between sources of different particle species as well as the average source size of the emitting system. The sizes of the pion and kaon sources increase with centrality, and pions are emitted closer to the centre of the system and/or later than kaons. This is naturally expected in a system with strong radial flow and is qualitatively reproduced by hydrodynamic models. ALICE data on pion-kaon emission asymmetry are consistent with (3+1)-dimensional viscous hydrodynamics coupled to a statistical hadronization model, resonance propagation, and decay code THERMINATOR 2 calculation, with an additional time delay between 1 and 2 fm/c for kaons. The delay can be interpreted as evidence for a significant hadronic rescattering phase in heavy-ion collisions at the LHC.
Pion–kaon femtoscopy and the lifetime of the hadronic phase in Pb−Pb collisions at √sNN = 2.76 TeV
(2020)
In this paper, the first femtoscopic analysis of pion-kaon correlations at the LHC is reported. The analysis was performed on the Pb-Pb collision data at sNN−−−√ = 2.76 TeV recorded with the ALICE detector. The non-identical particle correlations probe the spatio-temporal separation between sources of different particle species as well as the average source size of the emitting system. The sizes of the pion and kaon sources increase with centrality, and pions are emitted closer to the centre of the system and/or later than kaons. This is naturally expected in a system with strong radial flow and is qualitatively reproduced by hydrodynamic models. ALICE data on pion-kaon emission asymmetry are consistent with (3+1)-dimensional viscous hydrodynamics coupled to a statistical hadronization model, resonance propagation, and decay code THERMINATOR 2 calculation, with an additional time delay between 1 and 2 fm/c for kaons. The delay can be interpreted as evidence for a significant hadronic rescattering phase in heavy-ion collisions at the LHC.
The inclusive production of the J/ψ and ψ(2S) charmonium states is studied as a function of centrality in p-Pb collisions at a centre-of-mass energy per nucleon pair sNN−−−√ = 8.16 TeV at the LHC. The measurement is performed in the dimuon decay channel with the ALICE apparatus in the centre-of-mass rapidity intervals −4.46 < ycms < −2.96 (Pb-going direction) and 2.03 < ycms < 3.53 (p-going direction), down to zero transverse momentum (pT). The J/ψ and ψ(2S) production cross sections are evaluated as a function of the collision centrality, estimated through the energy deposited in the zero degree calorimeter located in the Pb-going direction. The pT-differential J/ψ production cross section is measured at backward and forward rapidity for several centrality classes, together with the corresponding average 〈pT〉 and ⟨p2T⟩ values. The nuclear effects affecting the production of both charmonium states are studied using the nuclear modification factor. In the p-going direction, a suppression of the production of both charmonium states is observed, which seems to increase from peripheral to central collisions. In the Pb-going direction, however, the centrality dependence is different for the two states: the nuclear modification factor of the J/ψ increases from below unity in peripheral collisions to above unity in central collisions, while for the ψ(2S) it stays below or consistent with unity for all centralities with no significant centrality dependence. The results are compared with measurements in p-Pb collisions at sNN−−−√ = 5.02 TeV and no significant dependence on the energy of the collision is observed. Finally, the results are compared with theoretical models implementing various nuclear matter effects.
This paper presents the measurements of π±, K±, p and p¯¯¯ transverse momentum (pT) spectra as a function of charged-particle multiplicity density in proton–proton (pp) collisions at s√ = 13 TeV with the ALICE detector at the LHC. Such study allows us to isolate the center-of-mass energy dependence of light-flavour particle production. The measurements reported here cover a pT range from 0.1 to 20 GeV/c and are done in the rapidity interval |y|<0.5. The pT-differential particle ratios exhibit an evolution with multiplicity, similar to that observed in pp collisions at s√ = 7 TeV, which is qualitatively described by some of the hydrodynamical and pQCD-inspired models discussed in this paper. Furthermore, the pT-integrated hadron-to-pion yield ratios measured in pp collisions at two different center-of-mass energies are consistent when compared at similar multiplicities. This also extends to strange and multi-strange hadrons, suggesting that, at LHC energies, particle hadrochemistry scales with particle multiplicity the same way under different collision energies and colliding systems.
The measurement of the azimuthal-correlation function of prompt D mesons with charged particles in pp collisions at s√=5.02 TeV and p–Pb collisions at sNN−−−√=5.02 TeV with the ALICE detector at the LHC is reported. The D0, D+, and D∗+ mesons, together with their charge conjugates, were reconstructed at midrapidity in the transverse momentum interval 3<pT<24 GeV/c and correlated with charged particles having pT>0.3 GeV/c and pseudorapidity |η|<0.8. The properties of the correlation peaks appearing in the near- and away-side regions (for Δφ≈0 and Δφ≈π, respectively) were extracted via a fit to the azimuthal correlation functions. The shape of the correlation functions and the near- and away-side peak features are found to be consistent in pp and p–Pb collisions, showing no modifications due to nuclear effects within uncertainties. The results are compared with predictions from Monte Carlo simulations performed with the PYTHIA, POWHEG+PYTHIA, HERWIG, and EPOS 3 event generators.
The pT-differential non-linear flow modes, v4,22, v5,32, v6,33 and v6,222 for π±, K±, K0S , p + p¯¯¯, Λ + Λ¯¯¯¯ and ϕ-meson have been measured for the first time at sNN−−−√ = 5.02 TeV in Pb-Pb collisions with the ALICE detector at the Large Hadron Collider. The results were obtained with a multi-particle technique, correlating the identified hadrons with reference charged particles from a different pseudorapidity region. These non-linear observables probe the contribution from the second and third order initial spatial anisotropy coefficients to higher flow harmonics. All the characteristic features observed in previous pT-differential anisotropic flow measurements for various particle species are also present in the non-linear flow modes, i.e. increase of magnitude with increasing centrality percentile, mass ordering at low pT and particle type grouping in the intermediate pT range. Hydrodynamical calculations (iEBE-VISHNU) that use different initial conditions and values of shear and bulk viscosity to entropy density ratios are confronted with the data at low transverse momenta. These calculations exhibit a better agreement with the anisotropic flow coefficients than the non-linear flow modes. These observations indicate that non-linear flow modes can provide additional discriminatory power in the study of initial conditions as well as new stringent constraints to hydrodynamical calculations.
This article reports measurements characterizing the Underlying Event (UE) associated with hard scatterings at midrapidity (|η| < 0.8) in pp collisions at s√ = 13 TeV. The hard scatterings are identified by the leading particle, the charged particle with the highest transverse momentum (pleadingT) in the event. Charged-particle number-densities and summed transverse-momentum densities are measured in different azimuthal regions defined with respect to the leading particle direction: Toward, Transverse, and Away. The Toward and Away regions contain the fragmentation products of the hard scatterings in addition to the UE contribution, whereas particles in the Transverse region are expected to originate predominantly from the UE. The study is performed as a function of pleadingT with three different pT thresholds for the associated particles, ptrackT > 0.15, 0.5, and 1.0 GeV/c. The charged-particle density in the Transverse region rises steeply for low values of pleadingT and reaches a plateau. The results confirm the trend that the charged-particle density in the Transverse region shows a stronger increase with s√ than the inclusive charged-particle density at midrapidity. The UE activity is increased by approximately 20% when going from 7 TeV to 13 TeV pp collisions. The plateau in the Transverse region (5 <pleadingT< 40 GeV/c) is further characterized by the probability distribution of its charged-particle multiplicity normalized to its average value (relative transverse activity, RT) and the mean transverse momentum as a function of RT. Experimental results are compared to model calculations using PYTHIA 8 and EPOS LHC. The overall agreement between models and data is within 30%. These measurements provide new insights on the interplay between hard scatterings and the associated UE in pp collisions.
The study of (anti-)deuteron production in pp collisions has proven to be a powerful tool to investigate the formation mechanism of loosely bound states in high-energy hadronic collisions. In this paper the production of (anti-)deuterons is studied as a function of the charged particle multiplicity in inelastic pp collisions at s√=13 TeV using the ALICE experiment. Thanks to the large number of accumulated minimum bias events, it has been possible to measure (anti-)deuteron production in pp collisions up to the same charged particle multiplicity (dNch/dη∼26) as measured in p–Pb collisions at similar centre-of-mass energies. Within the uncertainties, the deuteron yield in pp collisions resembles the one in p–Pb interactions, suggesting a common formation mechanism behind the production of light nuclei in hadronic interactions. In this context the measurements are compared with the expectations of coalescence and statistical hadronisation models (SHM).
The production of π±, K±, K0S, K∗(892)0, p, ϕ(1020), Λ, Ξ−, Ω−, and their antiparticles was measured in inelastic proton–proton (pp) collisions at a center-of-mass energy of s√ = 13 TeV at midrapidity (|y|<0.5) as a function of transverse momentum (pT) using the ALICE detector at the CERN LHC. Furthermore, the single-particle pT distributions of K0S, Λ, and Λ¯¯¯¯ in inelastic pp collisions at s√=7 TeV are reported here for the first time. The pT distributions are studied at midrapidity within the transverse momentum range 0≤pT≤20 GeV/c, depending on the particle species. The pT spectra, integrated yields, and particle yield ratios are discussed as a function of collision energy and compared with measurements at lower s√ and with results from various general-purpose QCD-inspired Monte Carlo models. A hardening of the spectra at high pT with increasing collision energy is observed, which is similar for all particle species under study. The transverse mass and xT≡2pT/s√ scaling properties of hadron production are also studied. As the collision energy increases from s√ = 7–13 TeV, the yields of non- and single-strange hadrons normalized to the pion yields remain approximately constant as a function of s√, while ratios for multi-strange hadrons indicate enhancements. The pT-differential cross sections of π±, K± and p (p¯¯¯) are compared with next-to-leading order perturbative QCD calculations, which are found to overestimate the cross sections for π± and p (p¯¯¯) at high pT.
Inclusive ψ(2S) production is measured in p-Pb collisions at the centre-of-mass energy per nucleon-nucleon pair sNN−−−√ = 8.16 TeV, using the ALICE detector at the CERN LHC. The production of ψ(2S) is studied at forward (2.03 < ycms < 3.53) and backward (−4.46 < ycms < −2.96) centre-of-mass rapidity and for transverse momentum pT < 12 GeV/c via the decay to muon pairs. In this paper, we report the integrated as well as the ycms- and pT-differential inclusive production cross sections. Nuclear effects on ψ(2S) production are studied via the determination of the nuclear modification factor that shows a strong suppression at both forward and backward centre-of-mass rapidities. Comparisons with corresponding results for inclusive J/ψ show a similar suppression for the two states at forward rapidity (p-going direction), but a stronger suppression for ψ(2S) at backward rapidity (Pb-going direction). As a function of pT, no clear dependence of the nuclear modification factor is found. The relative size of nuclear effects on ψ(2S) production compared to J/ψ is also studied via the double ratio of production cross sections [σψ(2S)/σJ/ψ]pPb/[σψ(2S)/σJ/ψ]pp between p-Pb and pp collisions. The results are compared with theoretical models that include various effects related to the initial and final state of the collision system and also with previous measurements at sNN−−−√ = 5.02 TeV.
The study of (anti-)deuteron production in pp collisions has proven to be a powerful tool to investigate the formation mechanism of loosely bound states in high energy hadronic collisions. In this paper the production of (anti-)deuterons is studied as a function of the charged particle multiplicity in inelastic pp collisions at s√=13 TeV using the ALICE experiment. Thanks to the large number of accumulated minimum bias events, it has been possible to measure (anti-)deuteron production in pp collisions up to the same charged particle multiplicity (dNch/dη∼26) as measured in p-Pb collisions at similar centre-of-mass energies. Within the uncertainties, the deuteron yield in pp collisions resembles the one in p-Pb interactions, suggesting a common formation mechanism behind the production of light nuclei in hadronic interactions. In this context the measurements are compared with the expectations of coalescence and Statistical Hadronisation Models (SHM).